Cellectis - ADR

NASDAQ:CLLS   3:59:58 PM EDT
31.22
+0.28 (+0.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.33B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.25 Million
Adjusted EPS-$0.78
See more estimates
10-Day MA$29.33
50-Day MA$25.69
200-Day MA$19.04
See more pivots

Cellectis S.A. Stock, NASDAQ:CLLS

8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE, FRANCE 75013
France
Phone: 33181691600
Number of Employees: 89

Description

Developing cancer immunotherapies based on gene-edited CAR T-cells.